|
1
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Larocca C, Cohen JR, Fernando RI, Huang B,
Hamilton DH and Palena C: An autocrine loop between TGF-β1 and the
transcription factor brachyury controls the transition of human
carcinoma cells into a mesenchymal phenotype. Mol Cancer Ther.
12:1805–1815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fernando RI, Litzinger M, Trono P,
Hamilton DH, Schlom J and Palena C: The T-box transcription factor
Brachyury promotes epithelial-mesenchymal transition in human tumor
cells. J Clin Invest. 120:533–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rowley M, Grothey E and Couch FJ: The role
of Tbx2 and Tbx3 in mammary development and tumorigenesis. J
Mammary Gland Biol Neoplasia. 9:109–118. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sinclair CS, Adem C, Naderi A, Soderberg
CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, et
al: TBX2 is preferentially amplified in BRCA1- and BRCA2-related
breast tumors. Cancer Res. 62:3587–3591. 2002.PubMed/NCBI
|
|
10
|
Wang B, Lindley LE, Fernandez-Vega V,
Rieger ME, Sims AH and Briegel KJ: The T box transcription factor
TBX2 promotes epithelial-mesenchymal transition and invasion of
normal and malignant breast epithelial cells. PLoS One.
7:e413552012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodriguez M, Aladowicz E, Lanfrancone L
and Goding CR: Tbx3 represses E-cadherin expression and enhances
melanoma invasiveness. Cancer Res. 68:7872–7881. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang B, Cohen JR, Fernando RI, Hamilton
DH, Litzinger MT, Hodge JW and Palena C: The embryonic
transcription factor Brachyury blocks cell cycle progression and
mediates tumor resistance to conventional antitumor therapies. Cell
Death Dis. 4:e6822013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the Carolina
Breast Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haffty BG, Yang Q, Reiss M, Kearney T,
Higgins SA, Weidhaas J, Harris L, Hait W and Toppmeyer D:
Locoregional relapse and distant metastasis in conservatively
managed triple negative early-stage breast cancer. J Clin Oncol.
24:5652–5657. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeong H, Ryu YJ, An J, Lee Y and Kim A:
Epithelial-mesenchymal transition in breast cancer correlates with
high histological grade and triple-negative phenotype.
Histopathology. 60:E87–E95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Palena C, Roselli M, Litzinger MT, Ferroni
P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI,
Hamilton DH, et al: Overexpression of the EMT driver brachyury in
breast carcinomas: Association with poor prognosis. J Natl Cancer
Inst. 106:dju0542014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hamilton DH, Roselli M, Ferroni P,
Costarelli L, Cavaliere F, Taffuri M, Palena C and Guadagni F:
Brachyury, a vaccine target, is overexpressed in triple-negative
breast cancer. Endocr Relat Cancer. 23:783–796. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heery CR, Singh BH, Rauckhorst M, Marte
JL, Donahue RN, Grenga I, Rodell TC, Dahut W, Arlen PM, Madan RA,
et al: Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine
(GI-6301) targeting the transcription factor brachyury. Cancer
Immunol Res. 3:1248–1256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge SB and Compton CC: American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimamatsu S, Okamoto T, Haro A, Kitahara
H, Kohno M, Morodomi Y, Tagawa T, Okano S, Oda Y and Maehara Y:
Prognostic significance of expression of the epithelial-mesenchymal
transition-related factor brachyury in intrathoracic lymphatic
spread of non-small cell lung cancer. Ann Surg Oncol. 23 Suppl
5:S1012–S1020. 2016. View Article : Google Scholar
|
|
23
|
R Development Core Team, . R: A Language
and Environment for Statistical Computing. The R Foundation for
Statistical Computing; Vienna: 2011, http://www.r-project.org/
|
|
24
|
Therneau TM: Survival: Survival Analysis.
R package version 2.38. 2015, https://CRAN.R-project.org/package=survival
|
|
25
|
Therneau TM and Grambsch PM: Modeling
survival data: Extending the Cox model. Springer; New York, NY:
2010
|
|
26
|
Kono M, Fujii T, Lim B, Karuturi MS,
Tripathy D and Ueno NT: Androgen receptor function and androgen
receptor-targeted therapies in breast cancer: A Review. JAMA Oncol.
3:1266–1273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kirsch T: Determinants of pathological
mineralization. Curr Opin Rheumatol. 18:174–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cox RF, Jenkinson A, Pohl K, O'Brien FJ
and Morgan MP: Osteomimicry of mammary adenocarcinoma cells in
vitro; increased expression of bone matrix proteins and
proliferation within a 3D collagen environment. PLoS One.
7:e416792012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Soltanoff CS, Yang S, Chen W and Li YP:
Signaling networks that control the lineage commitment and
differentiation of bone cells. Crit Rev Eukaryot Gene Expr.
19:1–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anderson HC: Vesicles associated with
calcification in the matrix of epiphyseal cartilage. J Cell Biol.
41:59–72. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scimeca M, Giannini E, Antonacci C,
Pistolese CA, Spagnoli LG and Bonanno E: Microcalcifications in
breast cancer: An active phenomenon mediated by epithelial cells
with mesenchymal characteristics. BMC Cancer. 14:2862014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Markiewicz A, Ahrends T,
Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Jaśkiewicz J,
Szade J, Biernat W and Zaczek AJ: Expression of epithelial to
mesenchymal transition-related markers in lymph node metastases as
a surrogate for primary tumor metastatic potential in breast
cancer. J Transl Med. 10:2262012. View Article : Google Scholar : PubMed/NCBI
|
